StockNews.com Begins Coverage on Avinger (NASDAQ:AVGR)

StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR) in a note issued to investors on Wednesday. The firm set a “hold” rating on the medical device company’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $5.00 price target on shares of Avinger in a report on Thursday, March 21st.

Avinger Trading Down 2.5 %

Shares of NASDAQ:AVGR opened at $3.69 on Wednesday. Avinger has a 12 month low of $2.50 and a 12 month high of $18.00. The company has a 50-day moving average price of $3.41 and a 200 day moving average price of $3.34. The company has a market cap of $5.87 million, a price-to-earnings ratio of -0.14 and a beta of 1.26.

Avinger (NASDAQ:AVGR) last announced its quarterly earnings results on Wednesday, March 20th. The medical device company reported ($3.93) EPS for the quarter, missing analysts’ consensus estimates of $0.64 by ($4.57). The company had revenue of $1.91 million for the quarter, compared to analysts’ expectations of $2.52 million. As a group, equities analysts forecast that Avinger will post -2.08 EPS for the current year.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.